SQSTM1 and adrenal cortex carcinoma: These trends were consistent with T stage data, where p62 expression was elevated in late-stage tumors (T3–T4) for BRCA, KIRP, LUAD, and THCA, but decreased in early-stage ACC and READ (T1–T2) (Fig. 3B).